{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:34:36Z","timestamp":1790620476326,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migraine, a neurovascular disorder evident by recurrent headaches, is associated with increased risk of ischemic vascular events, including ischemic stroke and myocardial infarction. Triptans, acute migraine\u2010specific treatment, cause vasoconstriction, complicating treatment decisions, especially for patients with migraine with cardiovascular risk factors. This study examined associations between triptan usage and cardiovascular (CV) events in patients with migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, population\u2010based cohort study conducted in southern Israel utilized data from Clalit Health Services. Electronic medical records from January 2000 to January 2022 were analyzed to assess triptan usage and CV events within 90\u2009days post\u2010purchase among patients aged \u226518\u2009years with a diagnosis of migraine based on International Classification of Diseases, Ninth Revision codes or triptan claims. Sensitivity analyses accounted for varying timeframes and usage patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 26,054 patients with migraine, 12,560 (48.2%) initiated triptan therapy. The prevalence of CV risk factors including dyslipidemia, diabetes mellitus, hypertension, smoking, atrial fibrillation, and obesity was higher in the non\u2010triptan group (standardized mean difference [SMD]\u2009=\u20090.028\u20130.289). The mean (standard deviation) number of triptan pills used per month was 1.9\u2009(1.5), with most patients (89.5%) using 1\u20134\u2009pills\/month. CV events within 90\u2009days occurred slightly more in the triptan group (5.1%) compared to the non\u2010triptan group (4.1%, SMD\u2009=\u20090.047). Multivariable analysis revealed no significant association between triptan use and increased CV events (adjusted hazard ratio 0.96, 95% confidence interval 0.77\u20131.23), controlling for demographic variables and CV risk factors. Sensitivity analyses also showed no significant risk with triptan use across different timeframes and usage patterns, reinforcing these findings. In the triptan group, patients with CV events were more likely to use triptans frequently, with a higher average number of pills per month.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This retrospective, population\u2010based study found that triptan usage did not increase CV risk among patients with migraine, even in those with existing CV risk factors, where no formal contraindication exists. The study highlights the importance of considering individual risk factors when prescribing triptans, as certain subgroups may still be at higher risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.14968","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T01:34:01Z","timestamp":1750642441000},"page":"1095-1106","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular risk and triptan usage among patients with migraine"],"prefix":"10.1111","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-1780","authenticated-orcid":false,"given":"Ido","family":"Peles","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"},{"name":"Clinical Research Center, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Smadar","family":"Shneyour","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"},{"name":"Clinical Research Center, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Levanon","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana Mechnik","family":"Steen","sequence":"additional","affiliation":[{"name":"Brain Medicine Division, Department of Neurology, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem","family":"Abu Salameh","sequence":"additional","affiliation":[{"name":"Brain Medicine Division, Department of Neurology, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Gordon","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Abuhasira","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"},{"name":"Clinical Research Center, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"},{"name":"Internal Medicine Division, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Novack","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"},{"name":"Clinical Research Center, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"},{"name":"Internal Medicine Division, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Ifergane","sequence":"additional","affiliation":[{"name":"Brain Medicine Division, Department of Neurology, Soroka University Medical Center Ben\u2010Gurion University of the Negev  Be'er Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,22]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30322-3"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12701"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10930-x"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020498"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38302.504063.8F"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01338-z"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k96"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a71220"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000151857.43225.49"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106375"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.04.007"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01937.x"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.01057.x"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.656603"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15198"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e328136c22d"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1017271"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13959"},{"issue":"1","key":"e_1_2_12_20_1","first-page":"S13","article-title":"Coronary vasoconstrictor potential of triptans: a review of in\u00a0vitro pharmacologic data","volume":"44","author":"Maassen Van Den Brink A","year":"2004","journal-title":"Headache"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152707781387314"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct0910887"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01513-w"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1828347"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.977306"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-012-0424-y"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3966"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.18865\/ed.26.3.323"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2005.00476.x"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12547"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02861.x"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01554.x"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30478-1"},{"key":"e_1_2_12_34_1","volume-title":"Sumatriptan Succinate Product Information","author":"US Food and Drug Administration","year":"2023"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14499"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.5549"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000110312.36809.7F"},{"issue":"10","key":"e_1_2_12_38_1","first-page":"602","article-title":"Acute myocardial infarction following the use of antimigraine therapy","volume":"16","author":"Mikhail GW","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04078.x"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-010-0258-4"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00435.x"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414550416"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:44:59Z","timestamp":1762073099000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.14968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1111\/head.14968"],"URL":"https:\/\/doi.org\/10.1111\/head.14968","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,22]]},"assertion":[{"value":"2024-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}